| Clinical Problem-Solving |
|
The After-Dinner Dip
G.L.G. Haverkamp, R.G. Ijzerman, J. Kooter, and Y.H.M. Krul-Poel
N Engl J Med 2022;386:2130-2136
|
|
|
 |
| Physician Jobs |
June 2, 2022 |
|
| Chiefs/Directors/Dept. Heads |
Canada |
|
| Toronto Research Institute seeks Director |
| Applications are invited for the Director, Lunenfeld-Tanenbaum Research Institute; Vice President, Research; and inaugural Lou Siminovitch Research Chair at Sinai Health System. Sinai Health is a fully-affiliated academic hospital of the University of Toronto, one of the world’s top ranked research universities. We are seeking an experienced leader, able to develop and implement a strategic research vision..... |
|
|
| Seeking epilepsy specialist for Hollywood practice |
| Memorial Healthcare System, located in south Florida, is looking for a fellowship-trained epilepsy specialist to join its growing epilepsy program. All candidates should be BE/BC in epilepsy or clinical neurophysiology. Candidate should have interest and experience in epilepsy surgery, particularly in applying stereotactic electroencephalography (SEEG) monitoring for seizure localization and mapping..... |
|
Looking for a new practice opportunity? View these jobs and other listings at NEJM CareerCenter.
Search now for both permanent and locum tenens jobs in many specialties.
|
|
|
| Subscribe to the New England Journal of Medicine |
| The New England Journal of Medicine delivers the most significant, most clinically relevant research in medicine. Advance your knowledge with the information you trust to stay informed and improve patient care. Your subscription includes 52 weeks of NEJM.org access, 50 FREE article views from the NEJM Archive (1812-1989), and free access to all NEJM Weekly CME activities (Choose from over 350). Subscribe today. |
|
 | | Question of the Week | | A 50-year-old woman with a 15-year history of type 2 diabetes and hypertension, a 25-pack-year history of cigarette smoking before quitting 3 years ago, and a family history of early myocardial infarction presents for evaluation. She has a blood pressure of 144/84 mm Hg (similar to home blood-pressure readings during the past month) while taking lisinopril 20 mg daily, an LDL-cholesterol level of 88 mg/dL and a triglyceride level of 180 mg/dL while taking atorvastatin 40 mg daily, and an estimated 4.3% risk of developing atherosclerotic cardiovascular disease in the next 10 years. Which one of the following strategies is most appropriate to further reduce this patient’s risk for cardiovascular disease? | | |  | |
|
|
